Nitroglycerin Articles
Abbott presents two-year data from ABSORB
20 October 2008
TMC's Cleviprex impresses in ECLIPSE trials
9 April 2007
NovaDel's NitroMist approved by FDA
13 November 2006
FDA requests extra Cellegesic trial
17 July 2006
ProStrakan to sell Cellegy drugs in CIS/Russia
3 July 2006
Headlines 25 years ago this week....
22 May 2006
Cellegy sells Australia unit to fund Cellegesic
24 April 2006
Novadel gets Nitromist FDA approvable letter
13 June 2005
NovaDel gets NitroMist appro letter from FDA
13 June 2005
Rectogesic: UK launch
6 June 2005
FDA rejects Cellegy's pain drug
10 January 2005
Cellegy and ProStrakan in Cellegesic deal
20 December 2004
FDA priority review for Cellegy's Cellegesic
25 October 2004
Cellegy's Cellegesic cleared in UK
20 September 2004
NovaDel licenses angina spray to Par
20 September 2004
NovaDel's nitroglycerin spray filed in USA
28 June 2004
Recordati pharma sales up, net slumps
22 March 2004
Positive new data for Cellegy's Cellegesic
2 February 2004
Cellegy issued patent for female sexual dysfunction therapy method
8 September 2003
Savage discontinues Nitrol product line
7 April 2003
Natrecor linked to higher mortality?
7 April 2003
Cellegy loss deepens as expenses increase
13 May 2002
Flemington files IND for nitroglycerin spray
13 May 2002
Cellegy pulls NDA for anal fissure drug
6 May 2002
Cellegy files for anal fissure treatment in Canada
1 April 2002
Cellegy losses deepen as sales to Gryphon fall
25 February 2002
Cellegy acquires Vaxis Therapeutics
30 November 2001
Celegy announces positive Ph III Anogesic results
4 October 2001
FDA OKs Scios' CHF drug, first in a decade
14 August 2001
Cellegy signs revenue share deal with Ventiv
10 August 2001
Cellegy files NDA for Anogesic
2 July 2001
Stock Commentary - New York
29 March 2001
Warner-Chilcott and Schering-Plough end agreement
20 July 2000
Cellegy completes Australian purchase
16 June 2000
Cellegy acquires Quay of Australia
18 April 2000
China sees over-supply, low demand for drugs
16 March 2000
Cellegy to press on with Anogesic development
24 December 1999
Cellegy shares crash on Anogesis data
24 November 1999
EU Approval of Viagra Due In September
26 August 1998
Cellegy's Glylorin Effective in Follow-Up Indication
19 August 1998
Pfizer's Impotence Pill Wins FDA Clearance
31 March 1998
Cellegy's Glyorin Falls At Phase III
11 March 1998
Eastern Europe/ Russia News Briefs
16 December 1996
Yamanouchi Looks To New Products For Growth
23 October 1995
Medicines' Contribution To Japanese health Care
25 September 1995
FDA revokes KV Pharmaceuticals request to produce three drugs
11 September 1995
FRISC Trial Casts Light On Antithrombotic Use
4 September 1995
Beleaguered Dutch Pharma Market Manages 5% Growth
21 August 1995
Benefits Of Drug Delivery Systems For Generics
5 June 1995
Watson Offers $606.5 Million For Circa
10 April 1995
Diabetic Leg Ulcer Solution
18 July 1994
ROBERTS COMPLETES APPLICATION FROM SEARLE
11 July 1994
ITALIAN POLICE SEIZE ILLICIT DRUGS MONEY
27 June 1994
ROBERTS COMPLETES ACQUISITION
16 May 1994
LIKELY IMPACT ON DRUG FIRMS OF ITALIAN REFORMS
17 January 1994
NEW TRIAL RESULTS REPORTED AT ECCO
20 September 1993
WARNER-LAMBERT CONSENT AGREEMENT
23 August 1993
THAILAND PATENT LAW:PIPELINE PROTECTION?
23 August 1993
CIRCA'S 1ST PRODUCT APPROVED BY FDA
16 August 1993
THERATECH FILES NDA
1 March 1993
WORLD PRODUCT NEWS IN BRIEF
18 January 1993
US GAO REPORT SLAMS DRUG PRICES
7 September 1992
Showing 1-72 of 72 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
